And according to Heiken-Ashi candles, this is still in a downtrend.
This has broken the neckline of the 2nd head and shoulders top. You can get a guesstimate of where a head and shoulders top may go by drawing a line from the head to the neckline, then projecting it downward from the neckline.
EW broke the neckline of the first bad/ugly top but did not fall far before resuming an uptrend again. I am not sure if this will be a regular occurrence anymore in our current market like if has been a for the last few years. But who knows?
Earnings Miss noted recently. As of late those do seem to matter, and can linger for a bit longer than they would have in the last few years
I like this stock but am watching for now. Earnings 3-27 AMC.
MKT cap 65.5 Billion. PE 40.94 (could be lower for this sector) Short interest less than 1%. EPS 2.56. Revenue is growing quarter after quarter
Oversold on daily RSI. Not oversold on weekly RSI but closing in on it and is by no mean oversold or monthly RSI, but is not overbought either. Securities can remain oversold for extended periods of time especially if there is a lot of supply at that level.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
If you can’t spot the sucker 30 minutes after sitting down at a table,
it’s probably you.
This has broken the neckline of the 2nd head and shoulders top. You can get a guesstimate of where a head and shoulders top may go by drawing a line from the head to the neckline, then projecting it downward from the neckline.
EW broke the neckline of the first bad/ugly top but did not fall far before resuming an uptrend again. I am not sure if this will be a regular occurrence anymore in our current market like if has been a for the last few years. But who knows?
Earnings Miss noted recently. As of late those do seem to matter, and can linger for a bit longer than they would have in the last few years
I like this stock but am watching for now. Earnings 3-27 AMC.
MKT cap 65.5 Billion. PE 40.94 (could be lower for this sector) Short interest less than 1%. EPS 2.56. Revenue is growing quarter after quarter
Oversold on daily RSI. Not oversold on weekly RSI but closing in on it and is by no mean oversold or monthly RSI, but is not overbought either. Securities can remain oversold for extended periods of time especially if there is a lot of supply at that level.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
If you can’t spot the sucker 30 minutes after sitting down at a table,
it’s probably you.
Comment:
This stock split a while back/Just FYI/Not a Reverse Split though.